JP7402495B2 - Operating method of health information detection device and health information detection device - Google Patents

Operating method of health information detection device and health information detection device Download PDF

Info

Publication number
JP7402495B2
JP7402495B2 JP2019216477A JP2019216477A JP7402495B2 JP 7402495 B2 JP7402495 B2 JP 7402495B2 JP 2019216477 A JP2019216477 A JP 2019216477A JP 2019216477 A JP2019216477 A JP 2019216477A JP 7402495 B2 JP7402495 B2 JP 7402495B2
Authority
JP
Japan
Prior art keywords
blood pressure
information detection
detection device
biological information
data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019216477A
Other languages
Japanese (ja)
Other versions
JP2021083917A (en
Inventor
健 飛岡
Original Assignee
株式会社人間と科学の研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社人間と科学の研究所 filed Critical 株式会社人間と科学の研究所
Priority to JP2019216477A priority Critical patent/JP7402495B2/en
Publication of JP2021083917A publication Critical patent/JP2021083917A/en
Priority to JP2023203818A priority patent/JP2024032019A/en
Application granted granted Critical
Publication of JP7402495B2 publication Critical patent/JP7402495B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Description

本発明は、被験者の健康状態や身体の異常を検出する健康情報検出方法及び装置に関し、特に糖尿病のリスク提示、ストレス状況のスクリーニング及び正確な血圧値を提供する健康情報検出方法及び装置に関する。 The present invention relates to a health information detection method and apparatus for detecting a subject's health condition and physical abnormality, and more particularly to a health information detection method and apparatus for providing diabetes risk presentation, stress situation screening, and accurate blood pressure values.

従来、各種センサを内蔵した生体情報検出装置を被験者のリストに装着し、被験者の血圧等を検出して健康を管理する装置やシステムが提案されている。例えば特開2016-134131号公報(特許文献1)に示される情報処理システムでは主として糖尿病を対象とし、リストに装着された生体情報検出装置から、血圧や脈拍等の生体情報を取得する情報取得部と、取得した生体情報を記憶する記憶部と、生体情報に基づいて処理を行う処理部とを含み、処理部は、生体情報に基づいて、被験者が糖質燃焼ゾーンに入った状態で行った運動情報の判定処理を行い、判定処理の結果を日付情報及び時刻情報の少なくとも一方を含む時間情報に関連づけた情報を、糖尿病の運動療法情報として表示する処理を行っている。 Conventionally, devices and systems have been proposed that manage the health of a subject by attaching a biological information detection device containing various sensors to the subject's wrist and detecting the subject's blood pressure and the like. For example, the information processing system disclosed in Japanese Patent Application Laid-Open No. 2016-134131 (Patent Document 1) mainly targets diabetes, and an information acquisition unit acquires biological information such as blood pressure and pulse rate from a biological information detection device attached to a wrist. , a storage unit that stores the acquired biological information, and a processing unit that performs processing based on the biological information, and the processing unit performs processing while the subject is in the carbohydrate burning zone based on the biological information. Processing is performed to determine exercise information, and information in which the results of the determination process are associated with time information including at least one of date information and time information is displayed as exercise therapy information for diabetes.

特開2016-134131号号公報Japanese Patent Application Publication No. 2016-134131 特開2017-63997号公報JP2017-63997A 特開2018-597号公報JP 2018-597 Publication 特開2019-198866号公報Japanese Patent Application Publication No. 2019-198866

しかしながら、特許文献1のシステムでは、脈拍数から血糖値を検出しており、正確性において問題がある。また、ストレスや心電波形といった健康に影響する要因を検出しておらず、健康管理において万全ではない。また、特開2017-63997号公報(特許文献2)では、脈拍や呼吸などを生体情報として検出して生体機能を検査しているが、センサが大がかりで睡眠中に検査するようになっている不都合がある。 However, the system of Patent Document 1 detects the blood sugar level from the pulse rate, which has a problem with accuracy. Additionally, it does not detect factors that affect health, such as stress and electrocardiogram waveforms, and is not perfect for health management. Furthermore, in Japanese Patent Application Laid-Open No. 2017-63997 (Patent Document 2), biological functions are tested by detecting pulse, breathing, etc. as biological information, but the sensor is large-scale and the test is performed during sleep. It's inconvenient.

本発明は上述のような事情よりなされたものであり、本発明の目的は、小型で腕のリストに簡単に装着可能であり、検出した心電信号及び脈拍のデータ処理と解析を行い、糖尿病のリスクの提示機能、ストレス状況のスクリーニング機能、動的変化に対しても精度の高い血圧検出機能を具備した健康情報検出方法及び装置を提供することにある。 The present invention has been made in view of the above-mentioned circumstances, and an object of the present invention is to provide a small-sized device that can be easily attached to the wrist of the arm, and to process and analyze detected electrocardiographic signals and pulses. It is an object of the present invention to provide a health information detection method and device that have a risk presentation function, a stress situation screening function, and a blood pressure detection function that is highly accurate even in response to dynamic changes.

本発明は、健康情報検出装置の作動方法及び健康情報検出装置に関し、本発明の上記目的は、生体情報検出部を備え、被験者のリストに装着可能な生体情報検出装置本体と、解析処理部と、を具備し、前記生体情報検出装置本体の前部若しくは後部には、心電信号を得るための鉤状の第1電極が設けられ、前記第1電極は、前記生体情報検出装置本体をリストに装着した時に、被験者の皮膚に接するか若しくは押圧する構造となっており、前記生体情報検出装置本体の上側表面にも他方の手を当てて心電信号を得るための突出した少なくとも2個以上の第2電極が設けられる健康情報検出装置の作動方法であって、前記解析処理部は、前記生体情報検出装置本体からの心電信号データ及び脈拍データを処理して、予め定めた表に対応した、糖尿病リスクの表示とストレス状況の表示とを行うと共に、血圧計で測定された血圧データを基に血圧値を演算して表示する、ことにより達成される。
The present invention relates to a method of operating a health information detection device and a health information detection device. , a hook-shaped first electrode for obtaining an electrocardiogram signal is provided at the front or rear of the biological information detection device main body, and the first electrode At least two or more protruding parts that are structured to touch or press against the subject's skin when worn on the body, and to obtain electrocardiographic signals by placing the other hand on the upper surface of the body of the biological information detection device. A method of operating a health information detection device provided with a second electrode, wherein the analysis processing section processes electrocardiographic signal data and pulse data from the body of the biological information detection device, and converts the data into a predetermined table. This is achieved by correspondingly displaying diabetes risk and stress status, as well as calculating and displaying blood pressure values based on blood pressure data measured by a blood pressure monitor.

本発明に係る健康情報検出方法及び装置によれば、小型の生体情報検出装置を腕部(リスト)に簡単に被験者に装着可能であり、生体情報検出装置で検出した心電信号及び脈拍のデータ処理と解析を行い、健康問題にとって重要な糖尿病,ストレス及び血圧に対して、糖尿病のリスクの提示、ストレス状況のスクリーニング、血圧の動的変化に対しても精度の高い血圧値を提供できる。 According to the health information detection method and device according to the present invention, a small biological information detection device can be easily attached to the arm (wrist) of a subject, and electrocardiographic signals and pulse rate data detected by the biological information detection device can be easily attached to the subject. Through processing and analysis, it can provide highly accurate blood pressure values for diabetes, stress, and blood pressure, which are important health issues, as well as presenting the risk of diabetes, screening for stress situations, and dynamic changes in blood pressure.

生体情報の検出は心電信号及び脈拍の2つであり、生体情報検出のためのセンサが少なくて済み、しかも健康に重要な糖尿病,ストレス及び血圧に対する情報を同時に提供できる。血圧に関しては従来の血圧計(血圧測定装置)の血圧データを(オンライン若しくはオフラインで)用いて演算処理し、より正確な血圧値を提供できる。 Detection of biological information consists of two types: electrocardiogram signals and pulse rates, so fewer sensors are required for detecting biological information, and information on diabetes, stress, and blood pressure, which are important for health, can be provided at the same time. Regarding blood pressure, blood pressure data from a conventional sphygmomanometer (blood pressure measurement device) is used for calculation processing (online or offline), and more accurate blood pressure values can be provided.

本発明に用いる生体情報検出装置の外観及び充電の様子を示す斜視図である。FIG. 2 is a perspective view showing the appearance and charging state of the biological information detection device used in the present invention. 本発明に係る健康情報検出装置の利用形態の一例を示す模式図である。1 is a schematic diagram showing an example of a usage form of a health information detection device according to the present invention. 生体情報検出装置及び載置台の内部構成例を示すブロック図である。FIG. 2 is a block diagram showing an example of the internal configuration of a biological information detection device and a mounting table. 本発明に係る解析処理部の構成例を示すブロック図である。FIG. 2 is a block diagram showing a configuration example of an analysis processing section according to the present invention. 心電信号センサの構成例を示すブロック図である。FIG. 2 is a block diagram showing a configuration example of an electrocardiographic signal sensor. 心電信号データと脈拍データの一例を示す波形図である。FIG. 3 is a waveform diagram showing an example of electrocardiographic signal data and pulse data. 脈拍波形の正常例と異常例を示す波形図である。FIG. 3 is a waveform diagram showing a normal example and an abnormal example of a pulse waveform. 自律神経活動(CVRR)と交感神経の関係を示す特性図である。It is a characteristic diagram showing the relationship between autonomic nerve activity (CVRR) and sympathetic nerves. 係数CVRRに対する糖尿病の可能性を例示する特性図である。FIG. 3 is a characteristic diagram illustrating the possibility of diabetes with respect to the coefficient CVRR. 自律神経のストレス表示を示す図である。FIG. 3 is a diagram showing stress display of autonomic nerves. 2本の回帰式を説明する特性図である。It is a characteristic diagram explaining two regression equations. 血圧値の演算を説明するための特性図である。FIG. 3 is a characteristic diagram for explaining calculation of blood pressure values. 生体情報検出装置の他の構成例を示す底面図である。FIG. 7 is a bottom view showing another configuration example of the biological information detection device.

糖尿病は、血液中のブドウ糖濃度(血糖、血糖値)が高い状態を指す病名である。糖尿病を放置すると、糖尿病神経障害、糖尿病網膜症、糖尿病腎症といった種々の合併症を引き起こし、手足のしびれや失明、白内障、腎機能の低下等、重篤な症状に繋がる恐れがある。そのため、糖尿病の検出や治療を行うシステムの重要性は非常に高く、例えば糖尿病の検出(判定)を行うものとして、特開2006-87603号公報等の手法が開示されている。また、糖尿病の治療手法は、病因や進行度に応じて異なるものであるが、食事療法、運動療法及び薬事療法が知られており、特に初期段階では食事療法と運動療法が重要となる。かかる状況から、被験者に対する糖尿病リスクの提示は、健康にとって非常に重要な要素である。 Diabetes is a disease name that refers to a state in which the concentration of glucose in the blood (blood sugar, blood sugar level) is high. If diabetes is left untreated, it can lead to various complications such as diabetic neuropathy, diabetic retinopathy, and diabetic nephropathy, which can lead to serious symptoms such as numbness in the hands and feet, blindness, cataracts, and decreased kidney function. Therefore, a system for detecting and treating diabetes is extremely important, and for example, a method for detecting (determining) diabetes has been disclosed in Japanese Patent Application Laid-Open No. 2006-87603. Treatment methods for diabetes vary depending on the cause and degree of progression, but diet therapy, exercise therapy, and pharmaceutical therapy are known, and diet therapy and exercise therapy are particularly important in the early stages. Under these circumstances, presenting the risk of diabetes to subjects is a very important element for health.

また、ストレスが命を奪いかねない脅威となっている報告もあり、人を死に至らしめることがあるストレスは「キラーストレス」と称されている。キラーストレスによって身体が過剰に反応し、脳細胞や血管が破壊されて死亡する可能性が高い病気を患ってしまう。ストレスはネガティブなことだけとは限らず、ポジティブな人が、個人的成功や長期休暇、レクリエーションの増加もストレスになり得ることが知られている。急性心筋梗塞や脳卒中も、ストレスが原因の1つになっているとする報告例もあり、過剰なストレスはホルモンバランスの崩れや過食症を引き起こし、結果的に肥満や糖尿病、高血圧へと発展する可能性があり、未然に防止するためのスクリーニングが重要となっている。 In addition, there are reports that stress poses a threat that can take away people's lives, and stress that can lead to death is called "killer stress." Killer stress causes the body to overreact, causing brain cells and blood vessels to be destroyed, resulting in a disease with a high possibility of death. Stress is not limited to negative things; it is known that for positive people, personal success, long vacations, and increased recreation can also be stressful. There are also reports that stress is one of the causes of acute myocardial infarction and stroke, and excessive stress causes hormonal imbalance and bulimia, which eventually leads to obesity, diabetes, and high blood pressure. There is a possibility of this happening, so screening to prevent it from happening is important.

更に、血圧値が人の健康にとって極めて重要な要素であることは周知の事実であり、如何に正確に血圧を測定できるかが問題となっている。 Furthermore, it is a well-known fact that blood pressure values are extremely important factors for human health, and how accurately blood pressure can be measured has become a problem.

本発明は、生体情報としての脈拍データ及び心電信号データに基づき、上述した糖尿病リスクの提示機能及びストレス・スクリーニング機能を提案すると共に、従来の血圧計乃至は血圧測定装置の血圧データ(オンライン若しくはオフライン)を用いて、回帰処理等の演算処理により、より正確な血圧値の測定を提案するものである。血圧に関しては、特に動的変化に対して検出精度を高めている。 The present invention proposes the above-mentioned diabetes risk presentation function and stress screening function based on pulse data and electrocardiographic signal data as biological information, and also proposes the blood pressure data of conventional blood pressure monitors or blood pressure measuring devices (online or It proposes more accurate measurement of blood pressure values through arithmetic processing such as regression processing using offline methods. Regarding blood pressure, the detection accuracy is particularly high for dynamic changes.

図1は、本発明に用いる生体情報検出装置本体100の外観構成と,生体情報検出装置本体100を載置台200の充電箇所201に載置して内臓バッテリを充電する様子を示しており、生体情報検出装置本体100は図2に示すように、長形状のバンド101A及び101Bをマジックテープ102で係止して、被験者の腕部(リスト)に装着されて利用される。図2では、左手のリストに生体情報検出装置本体100を装着した様子を示しているが、右手のリストに装着するようにしても良い。 FIG. 1 shows the external configuration of a biological information detection device main body 100 used in the present invention and how the internal battery is charged by placing the biological information detection device main body 100 on a charging point 201 of a mounting table 200. As shown in FIG. 2, the information detection device main body 100 is used by securing long bands 101A and 101B with Velcro tape 102 and attaching them to the arm (wrist) of the subject. Although FIG. 2 shows the biological information detection device main body 100 being worn on the wrist of the left hand, it may be worn on the wrist of the right hand.

図2の利用形態では、生体情報検出装置本体100から検出された生体情報が無線送信される場合を示しており、図2(A)のシステムは、生体情報検出装置本体100から生体情報が送信され、解析処理部300が直接生体情報を受信して、パソコン等で成る解析処理部300がデータ処理して解析した健康情報を出力するようになっている。また、図2(B)のシステムでは、生体情報検出装置本体100からの生体情報がネットワーク1を経て解析処理部300に入力されている。ネットワーク1は、移動通信網、インターネット等の公衆網、或いは固定電話網等を含むことができ、WAN(Wide Area Network)やLAN(Local Area Network)などにより実現することができ、有線・無線を問わない。また、図2(C)のシステムは、端末装置2を経てネットワーク1に接続され、ネットワーク1に解析処理部300が接続された例を示している。 The usage mode in FIG. 2 shows a case where biometric information detected from the biometric information detection device main body 100 is transmitted wirelessly, and the system in FIG. The analysis processing unit 300 directly receives the biological information, and the analysis processing unit 300, which is a personal computer or the like, processes the data and outputs the analyzed health information. Further, in the system shown in FIG. 2(B), biometric information from the biometric information detection device main body 100 is input to the analysis processing unit 300 via the network 1. The network 1 can include a mobile communication network, a public network such as the Internet, or a fixed telephone network, and can be realized by a WAN (Wide Area Network) or a LAN (Local Area Network), and can be wired or wireless. No question. Further, the system in FIG. 2C shows an example in which the system is connected to the network 1 via the terminal device 2, and the analysis processing unit 300 is connected to the network 1.

いずれの場合も、従来公知の血圧計(例えば市販されている電子式血圧測定装置)で測定された血圧データも、オンライン若しくはオフラインで解析処理部300に入力される。オンラインの場合には、測定された血圧値をディジタル信号で、そのまま有線若しくは無線で入力し、オフラインの場合には、その測定された血圧値を被験者」やオペレータ等が手入力する。また、図2では、生体情報検出装置本体100から生体情報が無線で出力される例を示しているが、有線や光通信でも良い。血圧計からの血圧データについても同様である。 In either case, blood pressure data measured with a conventionally known blood pressure monitor (for example, a commercially available electronic blood pressure measuring device) is also input to the analysis processing unit 300 online or offline. In the online case, the measured blood pressure value is directly input as a digital signal by wire or wirelessly, and in the offline case, the measured blood pressure value is manually input by the subject or operator. Further, although FIG. 2 shows an example in which biological information is output wirelessly from the biological information detection device main body 100, wired or optical communication may also be used. The same applies to blood pressure data from a sphygmomanometer.

生体情報検出装置本体100は、後述するようなメモリ等の電子素子やバッテリを内蔵しており、生体情報検出装置本体100を載置台200の充電箇所201に載置することにより、内臓バッテリ(130)が充電される。充電は、金属接点やコネクタ等を介さずに実施できる非接触充電方式で実施される。また、生体情報検出装置本体100は、充電時にメモリに蓄積された生体情報を読み出して外部に出力する手段(ACAT(Automatic Change And Transmission))を備えている。 The biological information detection device main body 100 has built-in electronic elements such as a memory and a battery as described later, and by placing the biological information detection device main body 100 on the charging point 201 of the mounting table 200, the built-in battery (130 ) is charged. Charging is performed using a non-contact charging method that can be performed without using metal contacts or connectors. The biological information detection device main body 100 also includes a means (ACAT (Automatic Change And Transmission)) for reading biological information stored in the memory during charging and outputting it to the outside.

生体情報検出装置本体100は外観が平板で矩形状の筐体であり、両サイドに、被験者のリストに巻回して装着するための革、布、ゴム等で成るバンド101A及び101Bを備えており、バンド101A及び101Bの各表面には、リスト寸法に合わせてリストに密着させて装着するためのマジックテープ102A及び102Bが層設されている。また、生体情報検出装置本体100の前部(若しくは後部)には、心電信号を得るための鉤状の第1電極110が設けられると共に、上側表面にも他方の手を当てて心電信号を得るための突出した第2電極111及び112が設けられている。生体情報検出装置本体100の上面には、検出と同時に情報を出力する同時送信モードと、検出した情報を一旦メモリに記憶した後に出力する記憶送信モードとを切り換えるためのモード切換スイッチ113が設けられている。 The biological information detection device main body 100 has a flat rectangular appearance, and is equipped with bands 101A and 101B made of leather, cloth, rubber, etc. on both sides to be wrapped around the subject's wrist and worn. , Velcro tapes 102A and 102B are layered on each surface of the bands 101A and 101B to fit the wrist in close contact with the wrist. In addition, a hook-shaped first electrode 110 for obtaining electrocardiographic signals is provided at the front (or rear) of the biological information detection device main body 100, and the electrocardiographic signal can be detected by placing the other hand on the upper surface. Protruding second electrodes 111 and 112 are provided for obtaining. A mode changeover switch 113 is provided on the top surface of the biological information detection device main body 100 for switching between a simultaneous transmission mode in which information is output at the same time as detection, and a storage transmission mode in which detected information is temporarily stored in a memory and then output. ing.

なお、第1電極110は、生体情報検出装置本体100をリストに装着した時に、被験者の皮膚に接するか若しくは押圧する構造となっている。また、生体情報検出装置本体100の上面に2個の111及び112の電極を設けた例を示しているが、電極110と合わせて少なくとも2個以上であれば、任意の数の電極とすることができる。 Note that the first electrode 110 is structured to come into contact with or press against the subject's skin when the biological information detection device main body 100 is worn on the wrist. Further, although an example is shown in which two electrodes 111 and 112 are provided on the top surface of the biological information detection device main body 100, any number of electrodes may be used as long as the electrodes are at least two or more in combination with the electrode 110. Can be done.

図3を参照して、生体情報検出装置本体100及び載置台200の構成例を説明する。 With reference to FIG. 3, a configuration example of the biological information detection device main body 100 and the mounting table 200 will be described.

生体情報検出装置本体100は生体情報検出部120を有しており、生体情報検出部120は脈拍センサ121及び心電信号センサ122で構成されている。脈拍センサ121は被検者の脈拍を測定し、所定時間間隔で脈拍データHRを出力し、心電信号センサ122は3個の電極110~112により被験者の心電信号ECを所定時間間隔で出力する。本例では、心電信号センサ122は3つの電極を有しており、被検者の心電信号を検出するために、それぞれの電極を被検者の身体(本例では、左腕リストに1ヶ所、右手に2ヶ所)に接触させて電位(電位信号)を測定し、測定された3つの電位差を所定時間間隔で心電信号データECとして出力する。測定される電位信号は微弱であり、心電信号センサ122内部の増幅器等で増幅されるので、ノイズの影響を受け易い。よって、ノイズの影響を低減しS/N比を向上させるために、電極や増幅器等は近接して配置される。 The biological information detection device main body 100 has a biological information detection section 120, and the biological information detection section 120 is composed of a pulse sensor 121 and an electrocardiographic signal sensor 122. The pulse sensor 121 measures the pulse of the subject and outputs pulse data HR at predetermined time intervals, and the electrocardiogram signal sensor 122 outputs the subject's electrocardiogram signal EC at predetermined time intervals using three electrodes 110 to 112. do. In this example, the electrocardiographic signal sensor 122 has three electrodes, and in order to detect the electrocardiographic signal of the subject, each electrode is attached to the subject's body (in this example, one on the left arm wrist). (2 locations on the right hand side) to measure the potential (potential signal), and output the three measured potential differences at predetermined time intervals as electrocardiographic signal data EC. The potential signal to be measured is weak and is amplified by an amplifier or the like inside the electrocardiographic signal sensor 122, so it is easily affected by noise. Therefore, in order to reduce the influence of noise and improve the S/N ratio, electrodes, amplifiers, etc. are arranged close to each other.

生体情報検出部120から出力される脈拍データHR及び心電信号データECは制御部140に入力され、制御部140は、入力された脈拍データHR及び心電信号データECを、データ毎に予め設定されたメモリ141内の領域にそれぞれ格納する。なお、脈拍データHR及び心電信号データECのメモリ141への格納方法は、データ毎に予め設定された領域に格納する方法に限られるのではなく、領域を設定せず、各データを区別する識別子を脈拍データHR及び心電信号データECにそれぞれ付加し、その識別子と共にメモリ141に格納する方法等でも良い。 The pulse data HR and electrocardiographic signal data EC output from the biological information detection section 120 are input to the control section 140, and the control section 140 sets the input pulse data HR and electrocardiographic signal data EC for each data in advance. The data are stored in the respective areas in the memory 141. Note that the method of storing the pulse rate data HR and the electrocardiographic signal data EC in the memory 141 is not limited to the method of storing each data in a preset area, but it is also possible to distinguish each data without setting an area. A method may also be used in which an identifier is added to each of the pulse rate data HR and electrocardiographic signal data EC and stored in the memory 141 together with the identifier.

また、生体情報検出装置本体100には、各素子に電力を供給するバッテリ130が内臓されており、バッテリ130は充電入力部131を介して充電される。充電入力部131による充電開始時には充電開始信号CSが出力され、充電開始信号CSは制御部140に入力される。 Further, the biological information detection device main body 100 includes a built-in battery 130 that supplies power to each element, and the battery 130 is charged via a charging input section 131. When the charging input unit 131 starts charging, a charging start signal CS is output, and the charging start signal CS is input to the control unit 140.

本例では、生体情報検出装置本体100を載置台200に載置してバッテリ130を充電する例を示しているが、バッテリ130に接続された充電用端子を設け、パソコンのUSB端子に充電用端子を挿入してバッテリ130を接触式に充電するようにしても良い。 In this example, the biological information detection device body 100 is placed on the mounting table 200 and the battery 130 is charged. The battery 130 may be charged in a contact manner by inserting a terminal.

モード切換スイッチ113により同時送信モードが設定されている場合には、制御部140は検出された生体情報RSAをメモリ141に記憶することなく送信部142に送信し、送信部142は生体情報RSを外部に出力する。モード切換スイッチ113により記憶送信モードが設定されている場合には、生体情報RSAを一旦メモリ141に記憶し、その後随時情報を読み出して送信部142に送信し、送信部142は生体情報RSを外部に出力する。この場合、検出された生体情報RSAをメモリ141に記憶すると同時に外部に無線送信することも、メモリ141に記憶するだけということもできる。送信部142は、入力された生体情報RSAを外部の解析処理部300が受信可能な形式に変換し、生体情報RSとして無線送信する。無線送信の方式として、ワイファイ(Wi-Fi)方式やブルートゥース(Blue tooth(登録商標))方式等を使用する。 When the simultaneous transmission mode is set by the mode changeover switch 113, the control unit 140 transmits the detected biological information RSA to the transmitting unit 142 without storing it in the memory 141, and the transmitting unit 142 transmits the biological information RS. Output to outside. When the storage transmission mode is set by the mode changeover switch 113, the biological information RSA is temporarily stored in the memory 141, and thereafter the information is read out at any time and transmitted to the transmitter 142, and the transmitter 142 transmits the biological information RS to an external device. Output to. In this case, the detected biological information RSA can be stored in the memory 141 and simultaneously transmitted wirelessly to the outside, or it can be simply stored in the memory 141. The transmitting unit 142 converts the input biometric information RSA into a format that can be received by the external analysis processing unit 300, and wirelessly transmits it as biometric information RS. As a wireless transmission method, a Wi-Fi method, a Bluetooth (registered trademark) method, or the like is used.

解析処理部300はパソコン等で構築され、受信した生体情報RS及び血圧計400からの血圧データBSを基に、被験者の健康状態や身体の異常等を解析する。これに関しては詳細に後述する。 The analysis processing unit 300 is constructed using a personal computer or the like, and analyzes the health condition and physical abnormalities of the subject based on the received biological information RS and blood pressure data BS from the blood pressure monitor 400. This will be discussed in detail later.

載置台200には、生体情報検出装置本体100のバッテリ130を充電するための充電出力部202が設けられており、載置台200に生体情報検出装置本体100を載置した時に、生体情報検出装置本体100の充電入力部131と、載置台200の充電出力部202とが丁度対向するように配置され、バッテリ130を非接触で充電することができる。即ち、生体情報検出装置本体100を載置台200に載置し、充電入力部131と充電出力部202を近接させると、生体情報検出装置本体100が必要とする電力が電磁誘導を利用した方式(電磁誘導方式)により供給される。充電入力部131と充電出力部202はそれぞれコイルを有しており、充電出力部202のコイルに電流が流れると磁束が発生し、その磁束に誘導されて、充電入力部131のコイルに電流が流れ、充電が行われる。非接触充電方式として、電磁誘導方式ではなく、共鳴方式等を使用しても良い。また、充電される電源としては、ニッケルカドミウム電池、リチウムイオン電池等の二次電池やスーパーキャパシタ(電気二重層コンデンサ)等を使用する。 The mounting table 200 is provided with a charging output section 202 for charging the battery 130 of the biological information detection device main body 100, and when the biological information detection device main body 100 is placed on the mounting table 200, the biological information detection device The charging input section 131 of the main body 100 and the charging output section 202 of the mounting table 200 are arranged to exactly face each other, so that the battery 130 can be charged without contact. That is, when the biological information detecting device main body 100 is placed on the mounting table 200 and the charging input section 131 and the charging output section 202 are brought close to each other, the electric power required by the biological information detecting device main body 100 is reduced by a method using electromagnetic induction ( (electromagnetic induction method). Charging input section 131 and charging output section 202 each have a coil, and when current flows through the coil of charging output section 202, magnetic flux is generated, and as a result of being induced by the magnetic flux, current flows through the coil of charging input section 131. current and charging takes place. As the non-contact charging method, a resonance method or the like may be used instead of the electromagnetic induction method. Further, as a power source for charging, a secondary battery such as a nickel cadmium battery or a lithium ion battery, a super capacitor (electric double layer capacitor), or the like is used.

また、載置台200には、生体情報検出装置本体100内の送信部142から無線送信される生体情報RSを受信する通信部203が設けられており、生体情報検出装置本体100のバッテリ130を充電している時に、メモリ141に記憶された生体情報RSAを送信部142が無線送信し、その生体情報RSAを通信部203が受信し、受信された生体情報RSBは通信部203より外部に出力される。これにより、生体情報を検出する環境や条件に合わせた生体情報の取得が可能となり、生体情報検出装置本体100の充電とメモリ141に蓄積された生体情報の取得を同時に行うことができる。 Further, the mounting table 200 is provided with a communication unit 203 that receives the biological information RS wirelessly transmitted from the transmitting unit 142 in the biological information detection device main body 100, and charges the battery 130 of the biological information detection device main body 100. When the body is running, the transmitting unit 142 wirelessly transmits the biometric information RSA stored in the memory 141, the communication unit 203 receives the biometric information RSA, and the received biometric information RSB is output from the communication unit 203 to the outside. Ru. This makes it possible to obtain biometric information in accordance with the environment and conditions for detecting biometric information, and to charge the biometric information detection device main body 100 and obtain the biometric information stored in the memory 141 at the same time.

図4は解析処理部300の構成例を示しており、脈拍データHR及び心電信号データECを含む生体情報RSは入力部310に入力され、入力部310を経てピーク検出部311に入力される。ピーク検出部311において脈拍データHR及び心電信号データECの各ピークが検出され、検出されたピーク信号PSはピーク間隔検出部312及び血圧演算部340に入力される。ピーク間隔検出部312はピーク信号PSに基づいて各データのピーク間隔RPIを検出し、ピーク間隔RPIを示すピーク間隔信号IPSは糖尿病リスク判定部320、ストレス・スクリーニング部330及び血圧演算部340に入力されて演算処理される。また、血圧計400からの血圧データBSは、血圧演算部340にオンライン若しくはオフラインで入力される。そして、糖尿病リスク判定部320からの判定信号DJ1、ストレス・スクリーニング部330からの判定信号DJ2及び血圧演算部340からの判定信号DJ3は出力部350を経て、被験者の健康情報DJとして出力される。 FIG. 4 shows a configuration example of the analysis processing section 300, in which biological information RS including pulse data HR and electrocardiographic signal data EC is input to the input section 310, and then input to the peak detection section 311 via the input section 310. . The peak detection unit 311 detects each peak of the pulse data HR and the electrocardiographic signal data EC, and the detected peak signal PS is input to the peak interval detection unit 312 and the blood pressure calculation unit 340. The peak interval detection unit 312 detects the peak interval RPI of each data based on the peak signal PS, and the peak interval signal IPS indicating the peak interval RPI is input to the diabetes risk determination unit 320, stress screening unit 330, and blood pressure calculation unit 340. The data is then processed. Further, blood pressure data BS from the blood pressure monitor 400 is input to the blood pressure calculation unit 340 online or offline. Then, the determination signal DJ1 from the diabetes risk determination section 320, the determination signal DJ2 from the stress screening section 330, and the determination signal DJ3 from the blood pressure calculation section 340 are outputted as health information DJ of the subject via the output section 350.

図5は心電信号センサ122の構成例を示しており、3個の電極110~112と電位差算出部122Aとで構成されている。3個の電極110~112は被検者の身体に接触若しくは押圧されて、その接触部分の電位を測定し、電位データe1、e2、e3をそれぞれ出力する。電極110が左手のリストに接触若しくは押圧されるとすれば、電極111及び112は右手の近接した2点に接触若しくは押圧されることになる。各電位データe1、e2及びe3は電位差算出部122Aに入力され、電位差算出部122Aは下記数1又は数2に従って電位差を算出し、所定間隔で心電信号データECを出力する。
(数1)
EC={(e1-e2)+(e1-e3)}/2
(数2)
EC=e1-(e2+e3)/2

このような構成において、生体情報検出装置本体100を図2に示すように、被験者の例えば左腕のリストにバンド101A及び101Bにより巻回して装着すると共に、右手を生体情報検出装置本体100の上に添える。生体情報検出装置本体100を右手に装着した場合には、左手を生体情報検出装置本体100の上に載置して添えることになる。これにより、生体情報検出装置本体100は、脈拍センサ121から脈拍データHRを取得すると共に、心電信号センサ122から心電信号データECを取得する。脈拍データHR及び心電信号データECは制御部140に入力され、送信部142を経て解析処理部300の入力部310に送信されると共に、メモリ141に記憶される。情報の送信は、モード切換スイッチ113のモードに従って行われる。
FIG. 5 shows an example of the configuration of the electrocardiographic signal sensor 122, which is composed of three electrodes 110 to 112 and a potential difference calculating section 122A. The three electrodes 110 to 112 are in contact with or pressed against the subject's body, measure the potential of the contact portion, and output potential data e1, e2, and e3, respectively. If the electrode 110 is contacted or pressed by the wrist of the left hand, the electrodes 111 and 112 will be contacted or pressed by two adjacent points on the right hand. Each potential data e1, e2, and e3 is input to the potential difference calculation unit 122A, and the potential difference calculation unit 122A calculates the potential difference according to Equation 1 or Equation 2 below, and outputs electrocardiographic signal data EC at predetermined intervals.
(Number 1)
EC={(e1-e2)+(e1-e3)}/2
(Number 2)
EC=e1-(e2+e3)/2

In such a configuration, as shown in FIG. 2, the biological information detection device main body 100 is worn around the wrist of the subject's left arm, for example, by wrapping it around the bands 101A and 101B, and the right hand is placed on the biological information detection device main body 100. Add. When the biological information detection device main body 100 is worn on the right hand, the left hand is placed on the biological information detection device main body 100 and attached. Thereby, the biological information detection device main body 100 acquires pulse data HR from the pulse sensor 121 and electrocardiographic signal data EC from the electrocardiographic signal sensor 122. Pulse data HR and electrocardiographic signal data EC are input to the control section 140, transmitted to the input section 310 of the analysis processing section 300 via the transmission section 142, and stored in the memory 141. Information is transmitted according to the mode of the mode changeover switch 113.

入力部310からの生体情報RSCはピーク検出部311に入力され、図6に示されるように、脈拍データHRのピークR11,R12,・・・R1n及び心電信号データECのピークR21,R22,・・・R2nが検出され、各ピークを示すピーク信号PSがピーク間隔検出部312及び血圧演算部340に入力され、図7に示すように各ピークのピーク間隔RRI1、RRI2,RRI3,・・・が検出され、ピーク間隔信号IPSとして糖尿病リスク提示部320、ストレス・スクリーニング部330及び血圧演算部340に入力される。 The biological information RSC from the input unit 310 is input to the peak detection unit 311, and as shown in FIG. 6, peaks R11, R12, ... R1n of the pulse data HR and peaks R21, R22, ... R2n is detected, and the peak signal PS indicating each peak is input to the peak interval detection section 312 and the blood pressure calculation section 340, and as shown in FIG. 7, the peak intervals RRI1, RRI2, RRI3, ... is detected and input as a peak interval signal IPS to the diabetes risk presentation unit 320, stress screening unit 330, and blood pressure calculation unit 340.

心電信号データECと脈拍データHR入力は相関関係があり(脈拍データHRは心電信号データECから遅れを持っている)、図7(A)及び(B)は脈拍データHRの波形例を示しているが、心電信号データECも同様なことが言える。ピーク検出部311は脈拍データHRのピークR11,R12,R13,R14を検出し、このピーク信号PSはピーク間隔検出部312に入力される。ピーク間隔検出部312はピークの間隔、つまりピークR11とピークR12の間隔RRI1、ピークR12とピークR13のピーク間隔RRI2、ピークR13とピークR14の間隔RRI3(以下同様)を順次検出し、これらピーク間隔RRI1、・・・を示すピーク間隔信号IPSが糖尿病リスク提示部320、ストレス・スクリーニング部330及び血圧演算部340に入力される。 There is a correlation between the electrocardiogram signal data EC and the pulse data HR input (the pulse data HR has a delay from the electrocardiogram signal data EC), and FIGS. 7(A) and (B) show waveform examples of the pulse data HR. However, the same can be said of the electrocardiographic signal data EC. The peak detection section 311 detects peaks R11, R12, R13, and R14 of the pulse data HR, and this peak signal PS is input to the peak interval detection section 312. The peak interval detection unit 312 sequentially detects the intervals between peaks, that is, the interval RRI1 between peak R11 and peak R12, the interval RRI2 between peak R12 and peak R13, and the interval RRI3 between peak R13 and peak R14 (the same applies hereinafter), and detects these peak intervals. A peak interval signal IPS indicating RRI1, .

心電検査時に、呼吸による脈拍数(心拍数)の変動の程度(図7のピーク間隔RRI1~RRI3)を測定することで、自律神経障害の評価を行うことができる。即ち、心臓副交感神経機能は呼気時に作用し、吸気時に変化しないので、脈拍数の変化率(RRI:RR Interval)を測定することで、自律神経障害の評価を行うことができる。図8は、自律神経活動(CVRR)と交感神経の関係を示す特性図であり、自律神経のストレス度を判定することができる。 Autonomic nerve disorder can be evaluated by measuring the degree of variation in pulse rate (heart rate) due to breathing (peak intervals RRI1 to RRI3 in FIG. 7) during electrocardiography. That is, since the cardiac parasympathetic nerve function acts during expiration and does not change during inspiration, autonomic nerve disorder can be evaluated by measuring the rate of change in pulse rate (RRI: RR Interval). FIG. 8 is a characteristic diagram showing the relationship between autonomic nerve activity (CVRR) and sympathetic nerves, and allows the degree of stress of autonomic nerves to be determined.

そこで、糖尿病リスク判定部320は、心電信号データEC若しくは脈拍データHRのピーク信号PS及びピーク間隔信号IPSに基づいてピーク間隔の変化率RRIVを求め、変化率RRIVからCVRR(Coefficient of Variation of RR Interval)と称される自律神経の活動度を正規化した係数を演算し、その係数CVRRから糖尿病のリスク提示を行う(CVRRの算出は、数3を参照)。図7の波形図において、正常な被験者は図7(A)に示すようにピーク間隔RRI1~RRI3はバラツクが、異常な被験者は図7(B)に示すようにピーク間隔RRI1~RRI3がほぼ均一でバラツキがない。また、東大医学部附属病院検査部の糖尿病教室の発表によると、係数CVRRの平均値と糖尿病との間には下記表1のような関係がある。即ち、30~59歳では、健常者の値は「3.5%」と高く、糖尿病患者では「2.2%」以下と低くなっており、60歳以上でも、健常者の値は「2.8%」と高く、糖尿病患者では「1.7%」以下と低くなっている。 Therefore, the diabetes risk determination unit 320 calculates the rate of change in the peak interval RRIV based on the peak signal PS and the peak interval signal IPS of the electrocardiographic signal data EC or the pulse data HR, and calculates the coefficient of variation of RR (CVRR) from the rate of change RRIV. A coefficient that normalizes the degree of activity of the autonomic nerve called ``Interval'' is calculated, and the risk of diabetes is presented from the coefficient CVRR (see Equation 3 for calculation of CVRR). In the waveform diagram of FIG. 7, the peak intervals RRI1 to RRI3 vary in normal subjects as shown in FIG. 7(A), and the peak intervals RRI1 to RRI3 are almost uniform in abnormal subjects as shown in FIG. 7(B). There is no variation. Furthermore, according to a presentation by the Department of Diabetes, Department of Laboratory Medicine, University of Tokyo Hospital, there is a relationship between the average value of the coefficient CVRR and diabetes as shown in Table 1 below. In other words, for those aged 30 to 59, the value for healthy people is high at ``3.5%,'' while for diabetic patients it is low at ``2.2%.'' Even for people aged 60 and over, the value for healthy people is ``2.5%.'' It is as high as .8%, and as low as 1.7% or less for diabetic patients.

Figure 0007402495000001
また、係数CVRRに対する糖尿病の可能性を図で示すと、図9のようになる。
Figure 0007402495000001
Further, the possibility of diabetes with respect to the coefficient CVRR is illustrated in FIG. 9.

係数CVRRの演算方法は公知であるが、ピーク間隔の分散値をσとし、ピーク間隔の平均値をMとすると、下記数3で表わされる。 The calculation method for the coefficient CVRR is well known, and it is expressed by the following equation 3, where σ is the variance value of the peak intervals and M is the average value of the peak intervals.

Figure 0007402495000002
上記数3で演算される係数CVRRを表1若しくは図9のデータと比較し、糖尿病リスク判定部320は、糖尿病のリスクを指示する判定信号DJ1を出力する。糖尿病のリスクとしているのは、本発明装置が医療機器ではなく、ヘルス機器としての健康情報検出装置であることと、「逆は真ならず」であり、本装置で演算された数値であっても、中には自律神経統合失調症やうつ病の可能性があるからである。しかし、糖尿病と診断された人々の係数CVRRは、表1の数値に殆どが入ることが分かっている。
Figure 0007402495000002
The coefficient CVRR calculated using Equation 3 above is compared with the data in Table 1 or FIG. 9, and the diabetes risk determination unit 320 outputs a determination signal DJ1 indicating the risk of diabetes. The risk of diabetes is based on the fact that the device of the present invention is not a medical device but a health information detection device as a health device, and ``the reverse is not true,'' and it is not the numerical value calculated by this device. This is because some patients may have autonomic schizophrenia or depression. However, it is known that most of the coefficients CVRR of people diagnosed with diabetes fall within the values shown in Table 1.

ストレス・スクリーニング部330は、心電信号データEC若しくは脈拍データHRのピーク信号PS及びピーク間隔信号IPSに基づいてピーク間隔の変化率を求め、変化率から係数CVRRを演算し、その係数CVRRから自律神経のストレスのスクリーニングを行う。即ち、上述した糖尿病の場合と同様に、心電信号データEC若しくは脈拍データHRのピーク信号PS及びピーク間隔信号IPSに基づいてピーク間隔の変化率RRIVを求め、変化率RRIVからCVRRと称される自律神経の活動度を正規化した係数CVRRを演算する。この係数CVRRが5%以上ではストレスは感じられず、健康的に良好であり、4~5%においても正常と判断される。しかし、係数CVRRが4%未満になると、何らかのストレス症状が現われる。従って、ストレス・スクリーニング部330は、下記表2に従ってスクリーニングの判定信号DJ2を出力する。係数CVRRに対するストレスは、詳細には図10に示されるようになっているので、図10に従って判定信号DJ2を出力しても良い。 The stress screening unit 330 calculates the rate of change in the peak interval based on the peak signal PS and peak interval signal IPS of the electrocardiogram signal data EC or the pulse data HR, calculates a coefficient CVRR from the rate of change, and calculates an autonomous coefficient from the coefficient CVRR. Perform neurological stress screening. That is, as in the case of diabetes described above, the change rate RRIV of the peak interval is determined based on the peak signal PS and the peak interval signal IPS of the electrocardiogram signal data EC or pulse data HR, and is called CVRR from the change rate RRIV. A coefficient CVRR is calculated by normalizing the degree of autonomic nerve activity. When this coefficient CVRR is 5% or more, stress is not felt and the person is healthy, and even when it is 4 to 5%, it is considered normal. However, when the coefficient CVRR becomes less than 4%, some stress symptoms appear. Therefore, the stress screening section 330 outputs the screening determination signal DJ2 according to Table 2 below. Since the stress on the coefficient CVRR is shown in detail in FIG. 10, the determination signal DJ2 may be output according to FIG.

Figure 0007402495000003
また、血圧演算部340はピーク検出部311からのピーク信号PS(心電信号データEC及び脈拍データHR)を入力すると共に、血圧計400から血圧データBSを入力し、図6に示すように心電信号データECのピークR11、R12・・・から脈拍データHRのピークR21、R22・・・までのパルス遷移時間Tp(n-1)、Tpn、・・・を求める。つまり、下記数4でパルス遷移時間Tpnを求める。
(数4)
Tpn=R1n-R2n

数4で求められたパルス遷移時間Tpnを用いて、収縮期血圧(最高血圧)BPS及び拡張期血圧(最低血圧)BPDを下記数5と回帰式で表記する。近似は最小自乗法により判定するが直線ではなく、事前に指定した関数の回帰式を求める場合もある(回帰方程式)。
Figure 0007402495000003
Further, the blood pressure calculation unit 340 inputs the peak signal PS (electrocardiogram signal data EC and pulse rate data HR) from the peak detection unit 311, and also inputs the blood pressure data BS from the sphygmomanometer 400, and as shown in FIG. The pulse transition times Tp(n-1), Tpn, . . . from the peaks R11, R12 . . . of the electrical signal data EC to the peaks R21, R22 . That is, the pulse transition time Tpn is determined using the following equation 4.
(Number 4)
Tpn=R1n-R2n

Using the pulse transition time Tpn obtained by Equation 4, the systolic blood pressure (systolic blood pressure) BPS and diastolic blood pressure (diastolic blood pressure) BPD are expressed using Equation 5 below and a regression equation. Approximation is determined by the method of least squares, but instead of a straight line, a regression equation of a prespecified function may be found (regression equation).

Figure 0007402495000004
数5内の(α、β)と(α、β)を実際に既に用いられている血圧計400を用いて、ランダムに抽出した被験者から測定した血圧データBSを用いて、最小二乗法でフィッティング後、収縮期血圧(最高血圧)BPS及び拡張期血圧(最低血圧)BPD、パルス遷移時間Tpnの平均分散とフィッティング係数を計算する。次いで、被験者の血圧を一定時間において数回採取し、それに上記回帰式で求めた血圧値とを比較し、その妥当性を最小二乗法でチェックする。
Figure 0007402495000004
s , β s ) and (α d , β d ) in Equation 5 are calculated as the minimum After fitting using the square method, the average variance and fitting coefficient of systolic blood pressure (systolic blood pressure) BPS, diastolic blood pressure (diastolic blood pressure) BPD, pulse transition time Tpn are calculated. Next, the subject's blood pressure is sampled several times over a certain period of time, and compared with the blood pressure value obtained using the regression equation described above, and its validity is checked using the method of least squares.

仮に上記回帰式が1本では相関が低い時、例えば図11に示すように年齢等の条件によりデータDTに差異が出るときは、更に年齢に応じた回帰式を追加し、A及びBの2本の回帰式とする。例えば20歳以下と20歳以上を別々の回帰式(図11では、Aが20歳以下,Bが20歳以上)で演算する。 If the correlation is low with only one regression equation above, for example, if there are differences in the data DT due to conditions such as age, as shown in Figure 11, then add a regression equation according to age and use the two regression equations A and B. Let's use the book's regression equation. For example, separate regression equations are calculated for those under 20 years old and those over 20 years old (in FIG. 11, A is under 20 years old and B is over 20 years old).

更に急激な運動後の血圧上昇に関しては、脈拍数に応じた補正値を導入する。先ず図12に示すように、脈拍数HRの平均値HRmを求め、次いで運動等により急激に上昇した脈拍数HRh(t)を求め、下記数6の補正値を演算する。ただし、γは実数値から決定する。 Furthermore, regarding the rapid increase in blood pressure after exercise, a correction value is introduced according to the pulse rate. First, as shown in FIG. 12, the average value HRm of the pulse rate HR is determined, then the pulse rate HRh(t) which has suddenly increased due to exercise or the like is determined, and the correction value shown in Equation 6 below is calculated. However, γ is determined from a real value.

Figure 0007402495000005
数6の補正値を静止時の血圧BPSに乗算し、血圧の変動時の血圧BPm(t)を下記数7に従って算出する。
Figure 0007402495000005
The blood pressure BPS at rest is multiplied by the correction value of Equation 6, and the blood pressure BPm(t) when the blood pressure fluctuates is calculated according to Equation 7 below.

Figure 0007402495000006
なお、健康情報検出装置をリストに装着する構造は、上述で述べたマジックテープに限定されるものではなく、従来公知の種々の手法を利用できる。また、上述では生体情報検出装置本体100から解析処理部300にデータを送信して処理するようになっているが、生体情報検出装置本体100内に解析処理部300を内蔵させることも可能である。
Figure 0007402495000006
Note that the structure for attaching the health information detection device to the wrist is not limited to the Velcro described above, and various conventionally known methods can be used. Furthermore, in the above description, data is transmitted from the biological information detection device main body 100 to the analysis processing section 300 for processing, but it is also possible to incorporate the analysis processing section 300 within the biological information detection device main body 100. .

更に、上述では生体情報検出装置本体100に3個(側面に1個、上面に2個)の電極110~112を設け、左右の手を使用して測定するようにしているが、図13に示すように生体情報検出装置本体100の底面に2個の電極110A及び110Bを設けて底面から突出させ、生体情報検出装置本体100を腕部に装着したときに、2個の電極110A及び110Bが皮膚に押圧若しくは密着する構造であっても良い。電極が2つあれば,例えば“e1-e2”の検出により心電信号データECを得ることができる。 Furthermore, in the above description, three electrodes 110 to 112 (one on the side and two on the top) are provided on the biological information detection device main body 100, and measurements are made using the left and right hands. As shown, two electrodes 110A and 110B are provided on the bottom surface of the biological information detection device main body 100 and protrude from the bottom surface, and when the biological information detection device main body 100 is attached to the arm, the two electrodes 110A and 110B It may have a structure that presses against or comes into close contact with the skin. If there are two electrodes, for example, electrocardiographic signal data EC can be obtained by detecting "e1-e2".

100 生体情報検出装置本体
101A,101B バンド
110、111、112 電極
113 モード切換スイッチ
120 生体情報検出部
121 脈拍センサ
122 心電信号センサ
130 バッテリ
140 制御部
200 載置台
201 充電箇所
202 充電出力部
203 通信部
300 解析処理部
310 入力部
311 ピーク検出部
312 ピーク間隔検出部
320 糖尿病リスク判定部
330 ストレス・スクリーニング部
340 血圧演算部
400 血圧計(血圧測定装置)
Reference Signs List 100 Biological information detection device main bodies 101A, 101B Bands 110, 111, 112 Electrodes 113 Mode changeover switch 120 Biological information detection section 121 Pulse sensor 122 Electrocardiographic signal sensor 130 Battery 140 Control section 200 Mounting table 201 Charging point 202 Charging output section 203 Communication Section 300 Analysis processing section 310 Input section 311 Peak detection section 312 Peak interval detection section 320 Diabetes risk determination section 330 Stress screening section 340 Blood pressure calculation section 400 Sphygmomanometer (blood pressure measurement device)

Claims (12)

生体情報検出部を備え、被験者のリストに装着可能な生体情報検出装置本体と、解析処理部と、を具備し、
前記生体情報検出装置本体の前部若しくは後部には、心電信号を得るための鉤状の第1電極が設けられ、前記第1電極は、前記生体情報検出装置本体をリストに装着した時に、被験者の皮膚に接するか若しくは押圧する構造となっており、前記生体情報検出装置本体の上側表面にも他方の手を当てて心電信号を得るための突出した少なくとも2個以上の第2電極が設けられる健康情報検出装置の作動方法であって、
前記解析処理部は、前記生体情報検出装置本体からの心電信号データ及び脈拍データを処理して、予め定めた表に対応した、糖尿病リスクの表示とストレス状況の表示とを行うと共に、血圧計で測定された血圧データを基に血圧値を演算して表示する、
ことを特徴とする健康情報検出装置の作動方法。
A biological information detection device main body that includes a biological information detection unit and can be attached to a wrist of a subject, and an analysis processing unit,
A hook-shaped first electrode for obtaining an electrocardiogram signal is provided at the front or rear part of the body of the biological information detection device, and the first electrode is configured to allow the body to detect when the body of the biological information detection device is worn on a wrist. It has a structure that contacts or presses the subject's skin, and has at least two or more protruding second electrodes for obtaining electrocardiographic signals by placing the other hand on the upper surface of the body of the biological information detection device body. A method of operating a health information detection device provided, the method comprising:
The analysis processing unit processes the electrocardiogram signal data and pulse data from the biological information detection device main body, displays diabetes risk and stress status according to a predetermined table, and also displays a blood pressure monitor. Calculates and displays blood pressure values based on blood pressure data measured by
A method of operating a health information detection device characterized by:
前記第2電極は、2つの電極を有し、前記心電信号データECは、前記第1電極の測定電位をe1、前記第2電極の測定電位を(e2、e3)とした時に、下記(式1)を用いる請求項1に記載の健康情報検出装置の作動方法。
(式1)
Figure 0007402495000007
The second electrode has two electrodes, and the electrocardiographic signal data EC is expressed as follows (where e1 is the measured potential of the first electrode and (e2, e3) are the measured potentials of the second electrode). 2. The method of operating a health information detection device according to claim 1, using equation 1).
(Formula 1)
Figure 0007402495000007
前記血圧値は、
前記解析処理部の血圧演算部に、前記解析処理部のピーク検出部からのピーク信号PSを入力すると共に、前記血圧計から前記血圧データBSを入力し、前記心電信号データECのピークから前記脈拍データHRのピーク迄のパルス遷移時間Tpnを求め、前記パルス遷移時間Tpnを用いて、最高血圧BPS及び最低血圧BPDを下記(式2)と回帰式で表記し、
(式2)
Figure 0007402495000008
前記(式2)内の(α、β)と(α、β)を前記血圧計を用いて、ランダムに抽出した被験者から測定した前記血圧データBSを用いて、最小二乗法でフィッティング後、前記最高血圧BPS及び前記最低血圧BPD、前記パルス遷移時間Tpnの平均分散とフィッティング係数を計算し、被験者の血圧を一定時間において数回採取し、それに前記回帰式で求めた血圧値とを比較し、その妥当性を最小二乗法でチェックする、請求項1又は2に記載の健康情報検出装置の作動方法。
The blood pressure value is
The peak signal PS from the peak detection section of the analysis processing section is input to the blood pressure calculation section of the analysis processing section , and the blood pressure data BS from the sphygmomanometer is inputted to the blood pressure calculation section of the analysis processing section. Find the pulse transition time Tpn to the peak of the pulse rate data HR, and use the pulse transition time Tpn to express the systolic blood pressure BPS and diastolic blood pressure BPD using the following (Equation 2) and regression equation,
(Formula 2)
Figure 0007402495000008
s , β s ) and (α d , β d ) in the above (Equation 2) are calculated using the least squares method using the blood pressure data BS measured from randomly selected subjects using the blood pressure monitor. After fitting, the average variance and fitting coefficient of the systolic blood pressure BPS, the diastolic blood pressure BPD, and the pulse transition time Tpn are calculated, and the blood pressure of the subject is sampled several times in a certain period of time, and the blood pressure value obtained using the regression equation is calculated. 3. The method of operating a health information detection device according to claim 1, wherein the validity of the comparison is checked using a least squares method.
運動後の血圧上昇に関して、脈拍数HRの平均値HRmと、運動時の脈拍数HRh(t)とに基づいて(但し、γは実数から決定する)、下記(式3)の補正値を演算すると共に、
(式3)
Figure 0007402495000009
前記補正値を静止時の血圧に乗算して、変動時の血圧を算出する、請求項1乃至3のいずれか1項に記載の健康情報検出装置の作動方法。
Regarding the increase in blood pressure after exercise, calculate the correction value shown below (Equation 3) based on the average value HRm of pulse rate HR and the pulse rate HRh(t) during exercise (however, γ is determined from a real number). At the same time,
(Formula 3)
Figure 0007402495000009
4. The method of operating a health information detection device according to claim 1, wherein the blood pressure at rest is calculated by multiplying the correction value by the blood pressure at rest to calculate the blood pressure at a time of fluctuation.
前記生体情報検出装置は、
前記被験者の片方のリストに装着された前記生体情報検出装置本体に、前記被験者が他方の手を接触若しくは押圧させることにより、前記心電信号データ及び前記脈拍データを取得する請求項1乃至4のいずれか1項に記載の健康情報検出装置の作動方法。
The biological information detection device includes:
5. The electrocardiographic signal data and the pulse rate data are acquired by the subject touching or pressing the other hand of the biological information detection device body attached to one of the wrists of the subject. A method for operating the health information detection device according to any one of the items.
前記心電信号データ及び前記脈拍データの送受信を無線により行う請求項1乃至5のいずれか1項に記載の健康情報検出装置の作動方法。 6. The method of operating a health information detection device according to claim 1, wherein the electrocardiographic signal data and the pulse data are transmitted and received wirelessly. 生体情報検出部を備え、被験者のリストに装着可能な生体情報検出装置本体と、
前記生体情報検出装置本体からの心電信号データ及び脈拍データを処理して、予め定めた表に対応した、糖尿病リスクの表示とストレス状況の表示とを行うと共に、血圧計で測定された血圧データを基に血圧値を演算して表示する解析処理部と、を具備し、
前記生体情報検出装置本体の前部若しくは後部には、心電信号を得るための鉤状の第1電極が設けられ、前記第1電極は、前記生体情報検出装置本体をリストに装着した時に、被験者の皮膚に接するか若しくは押圧する構造となっており、前記生体情報検出装置本体の上側表面にも他方の手を当てて心電信号を得るための突出した少なくとも2個以上の第2電極が設けられ、ることを特徴とする健康情報検出装置。
A biological information detection device main body that includes a biological information detection unit and can be attached to a subject's wrist;
The electrocardiographic signal data and pulse rate data from the body of the biological information detection device are processed to display diabetes risk and stress status according to a predetermined table, as well as blood pressure data measured by a sphygmomanometer. an analysis processing unit that calculates and displays a blood pressure value based on the
A hook-shaped first electrode for obtaining an electrocardiogram signal is provided at the front or rear part of the body of the biological information detection device, and the first electrode is configured to provide a first electrode when the body of the body of the biological information detection device is worn on a wrist. It has a structure that contacts or presses the subject's skin, and has at least two or more protruding second electrodes for obtaining electrocardiographic signals by placing the other hand on the upper surface of the body of the biological information detection device. A health information detection device comprising:
前記第2電極は、2つの電極を有し、前記心電信号データECは、前記第1電極の測定電位をe1、前記第2電極の測定電位を(e2、e3)とした時に、下記(式1)を用いる請求項7に記載の健康情報検出装置。
(式1)
Figure 0007402495000010
The second electrode has two electrodes, and the electrocardiographic signal data EC is expressed as follows (where the measured potential of the first electrode is e1 and the measured potential of the second electrode is (e2, e3)). The health information detection device according to claim 7, which uses equation 1).
(Formula 1)
Figure 0007402495000010
前記血圧値は、
前記解析処理部の血圧演算部に、ピーク検出部からのピーク信号PSを入力すると共に、前記血圧計から血圧データBSを入力し、前記心電信号データECのピークから前記脈拍データHRのピーク迄のパルス遷移時間Tpnを求め、前記パルス遷移時間Tpnを用いて、最高血圧BPS及び最低血圧BPDを下記(式2)と回帰式で表記し、
(式2)
Figure 0007402495000011
前記(式2)内の(α、β)と(α、β)を前記血圧計を用いて、ランダムに抽出した被験者から測定した前記血圧データBSを用いて、最小二乗法でフィッティング後、最高血圧BPS及び最低血圧BPD、パルス遷移時間Tpnの平均分散とフィッティング係数を計算し、被験者の血圧を一定時間において数回採取し、それに前記回帰式で求めた血圧値とを比較し、その妥当性を最小二乗法でチェックする、請求項7又は8に記載の健康情報検出装置。
The blood pressure value is
The peak signal PS from the peak detection section is inputted to the blood pressure calculation section of the analysis processing section, and the blood pressure data BS from the sphygmomanometer is inputted, and from the peak of the electrocardiographic signal data EC to the peak of the pulse rate data HR. Find the pulse transition time Tpn, and use the pulse transition time Tpn to express the systolic blood pressure BPS and diastolic blood pressure BPD using the following (Equation 2) and regression equation,
(Formula 2)
Figure 0007402495000011
s , β s ) and (α d , β d ) in the above (Equation 2) are calculated using the least squares method using the blood pressure data BS measured from randomly selected subjects using the blood pressure monitor. After fitting, calculate the average variance and fitting coefficient of systolic blood pressure BPS, diastolic blood pressure BPD, and pulse transition time Tpn, collect the subject's blood pressure several times at a certain time, and compare it with the blood pressure value obtained by the regression equation. , the health information detection device according to claim 7 or 8, wherein the validity thereof is checked by a least squares method.
運動後の血圧上昇に関しては、脈拍数HRの平均値HRmと、運動時の脈拍数HRh(t)とに基づいて(但し、γは実数から決定する)、下記(式3)の補正値を演算すると共に、
(式3)
Figure 0007402495000012
前記補正値を静止時の血圧に乗算して、変動時の血圧を算出する、請求項9に記載の健康情報検出装置。
Regarding the increase in blood pressure after exercise, based on the average value HRm of pulse rate HR and the pulse rate HRh(t) during exercise (however, γ is determined from a real number), the following (Equation 3) correction value is calculated. Along with calculating,
(Formula 3)
Figure 0007402495000012
The health information detection device according to claim 9, wherein the blood pressure at rest is multiplied by the correction value to calculate the blood pressure at the time of fluctuation.
前記生体情報検出装置本体と前記解析処理部との間の送受信を無線で行う請求項7乃至10のいずれか1項に記載の健康情報検出装置。 The health information detection device according to any one of claims 7 to 10, wherein transmission and reception between the biological information detection device main body and the analysis processing section are performed wirelessly. 前記送受信を、端末装置、ネットワークを介して行う請求項11に記載の健康情報検出装置。
The health information detection device according to claim 11, wherein the transmission and reception is performed via a terminal device and a network.
JP2019216477A 2019-11-29 2019-11-29 Operating method of health information detection device and health information detection device Active JP7402495B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019216477A JP7402495B2 (en) 2019-11-29 2019-11-29 Operating method of health information detection device and health information detection device
JP2023203818A JP2024032019A (en) 2019-11-29 2023-12-01 Operation method of health information detection device and health information detection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2019216477A JP7402495B2 (en) 2019-11-29 2019-11-29 Operating method of health information detection device and health information detection device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023203818A Division JP2024032019A (en) 2019-11-29 2023-12-01 Operation method of health information detection device and health information detection device

Publications (2)

Publication Number Publication Date
JP2021083917A JP2021083917A (en) 2021-06-03
JP7402495B2 true JP7402495B2 (en) 2023-12-21

Family

ID=76086049

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019216477A Active JP7402495B2 (en) 2019-11-29 2019-11-29 Operating method of health information detection device and health information detection device
JP2023203818A Pending JP2024032019A (en) 2019-11-29 2023-12-01 Operation method of health information detection device and health information detection device

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023203818A Pending JP2024032019A (en) 2019-11-29 2023-12-01 Operation method of health information detection device and health information detection device

Country Status (1)

Country Link
JP (2) JP7402495B2 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002172094A (en) 2000-12-06 2002-06-18 Casio Comput Co Ltd Blood pressure measurement system and blood pressure arithmetic unit
JP2003230541A (en) 2002-02-08 2003-08-19 Nippon Colin Co Ltd Superior limb-inferior limb blood pressure index- measuring system
WO2014184868A1 (en) 2013-05-14 2014-11-20 株式会社 東芝 Electronic device and biosignal measurement method
JP2016154754A (en) 2015-02-25 2016-09-01 セイコーエプソン株式会社 Biological information measurement device
US20170143279A1 (en) 2015-11-20 2017-05-25 Tata Consultancy Services Limited Device and method to detect diabetes in a person using pulse palpation signal
JP2017099527A (en) 2015-11-30 2017-06-08 株式会社人間と科学の研究所 Mind and body condition diagnosis support device and biological information management system
JP2019180622A (en) 2018-04-05 2019-10-24 オムロンヘルスケア株式会社 Blood pressure measuring device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002172094A (en) 2000-12-06 2002-06-18 Casio Comput Co Ltd Blood pressure measurement system and blood pressure arithmetic unit
JP2003230541A (en) 2002-02-08 2003-08-19 Nippon Colin Co Ltd Superior limb-inferior limb blood pressure index- measuring system
WO2014184868A1 (en) 2013-05-14 2014-11-20 株式会社 東芝 Electronic device and biosignal measurement method
JP2016154754A (en) 2015-02-25 2016-09-01 セイコーエプソン株式会社 Biological information measurement device
US20170143279A1 (en) 2015-11-20 2017-05-25 Tata Consultancy Services Limited Device and method to detect diabetes in a person using pulse palpation signal
JP2017099527A (en) 2015-11-30 2017-06-08 株式会社人間と科学の研究所 Mind and body condition diagnosis support device and biological information management system
JP2019180622A (en) 2018-04-05 2019-10-24 オムロンヘルスケア株式会社 Blood pressure measuring device

Also Published As

Publication number Publication date
JP2024032019A (en) 2024-03-08
JP2021083917A (en) 2021-06-03

Similar Documents

Publication Publication Date Title
JP4243605B2 (en) Autonomic nerve inspection device
KR100927643B1 (en) Unrestrained sleep state determination device
US20160367157A1 (en) Wearable physiological monitoring and notification system based on real-time heart rate variability analysis
JP4754447B2 (en) Biological analysis apparatus and program
JP4487015B1 (en) Autonomic nerve function evaluation apparatus and program
JP7262006B2 (en) STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD AND PROGRAM
JP5327458B2 (en) Mental stress evaluation, device using it and its program
US20170215782A1 (en) Method for determining a depression state and depression state determination device
JP6579890B2 (en) Fatigue meter
Seeberg et al. A novel method for continuous, noninvasive, cuff-less measurement of blood pressure: evaluation in patients with nonalcoholic fatty liver disease
CN109350020A (en) Psychosomatic health analytical equipment and method
EP3533389A1 (en) Methods and systems for measuring a stress indicator, and for determining a level of stress in an individual
US20200113454A1 (en) Vibration sensing device
JP2017063966A (en) Fatigue degree meter
RU2442531C2 (en) Means of remote humain state monitoring
JP5882169B2 (en) Autonomic nerve function evaluation apparatus and program
US20200359909A1 (en) Monitoring device including vital signals to identify an infection and/or candidates for autonomic neuromodulation therapy
JP5480800B2 (en) Autonomic nerve function diagnosis apparatus and program
US20180055373A1 (en) Monitoring device to identify candidates for autonomic neuromodulation therapy
JP5592323B2 (en) Autonomic nerve function diagnosis apparatus and program
EP3417771A1 (en) A method for monitoring blood pressure, and a device thereof
KR101858051B1 (en) Portable analysis apparatus for bio-signal
KR20120007882U (en) Home health care device
WO2019230235A1 (en) Stress evaluation device, stress evaluation method, and program
JP7402495B2 (en) Operating method of health information detection device and health information detection device

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20221110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221111

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230620

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230808

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231102

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231108

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231204

R150 Certificate of patent or registration of utility model

Ref document number: 7402495

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150